|
|
|
51-200 employees
View all
|
|
Information Technology & Services
|
|
180 Varick Street, 6th Floor, New York, New York 10014, US
|
|
Intelligencia uses Artificial Intelligence to de-risk drug development. Our platform focuses on estimating the risk of clinical trials, and interpreting the multitude of factors that contribute to that risk. We therefore aim to bridge the gap between innovation and risk reduction, with the ultimate goal of bringing novel therapies to patients faster.
Our interdisciplinary team of software engineers, AI practitioners, scientists, and drug developers brings together and interprets disparate data across the life sciences industry. Our platform offers a suite of functionalities that provide unprecedented data clarity and Machine-Learning fueled predictions to enable critical decision making.
We currently work with several of the largest global pharmaceutical companies, as well as with mid-size and smaller biotechnology companies.
Diseases will impact nearly every individual. At Intelligencia, we work to make a difference.
|
Intelligencia Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
100%
|
The widely used Intelligencia email format is {first}.{last} (e.g. [email protected]) with 100% adoption across the company.
To contact Intelligencia customer service number call here +1.212.653.8329. To contact Intelligencia customer service number in your country click here to find.
Dimitrios Skaltsas is the CEO of Intelligencia. To contact Dimitrios Skaltsas email at [email protected], [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.